These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2166998)

  • 1. The pathogenesis of Burkitt's lymphoma.
    Magrath I
    Adv Cancer Res; 1990; 55():133-270. PubMed ID: 2166998
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis.
    Dalla-Favera R; Lombardi L; Pelicci PG; Lanfrancone L; Cesarman E; Neri A
    Ann N Y Acad Sci; 1987; 511():207-18. PubMed ID: 2830825
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosome translocations in B and T cell neoplasias.
    Showe LC; Croce CM
    Semin Hematol; 1986 Oct; 23(4):237-44. PubMed ID: 3535082
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I; Jain V; Bhatia K
    Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis.
    Dis Markers; 1990; 8(3):162. PubMed ID: 2176940
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation in Burkitt's lymphoma cells.
    Hörtnagel K; Polack A; Mautner J; Feederle R; Bornkamm GW
    Curr Top Microbiol Immunol; 1995; 194():415-22. PubMed ID: 7895517
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(2;18) and t(18;22) variant chromosomal translocations in B cell malignancies.
    Bertheas MF; Bachy M; Magaud JP; Rimokh R; Vasselon C; Berger F; Oriol PC; Jaubert J; Reynaud J; Brizard CP
    Leuk Lymphoma; 1992 Oct; 8(3):197-200. PubMed ID: 1490147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
    Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
    Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of chromosome 8 breakpoint location in Burkitt's lymphoma: correlation with geographical origin and association with Epstein-Barr virus.
    Barriga F; Kiwanuka J; Alvarez-Mon M; Shiramizu B; Huber B; Levine P; Magrath I
    Curr Top Microbiol Immunol; 1988; 141():128-37. PubMed ID: 2850892
    [No Abstract]   [Full Text] [Related]  

  • 14. Forward and reverse changes in Ig/myc translocation carrying tumors.
    Klein G
    Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Burkitt's lymphoma in 1985].
    Philip T; Lenoir GM; Favrot M; Philip I; Brunat-Mentigny M
    Pediatrie; 1985 Mar; 40(2):137-60. PubMed ID: 3001632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome.
    Vandenberghe E; Van Hove J; Brock P; Schmidt P; Delabie J; Casteels-Van Daele M; Cassiman JJ; Vanderschueren-Lodeweyckx M; Van den Berghe H
    Leuk Lymphoma; 1993 Jul; 10(4-5):377-82. PubMed ID: 8220137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes.
    Aya T; Kinoshita T; Imai S; Koizumi S; Mizuno F; Osato T; Satoh C; Oikawa T; Kuzumaki N; Ohigashi H
    Lancet; 1991 May; 337(8751):1190. PubMed ID: 1673740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible mechanisms of activation of the cellular myc gene in Burkitt's lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1986; 40(1):96-110. PubMed ID: 3532072
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
    Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
    zur Stadt U; Reiter A; Welte K; Sykora KW
    Klin Padiatr; 1997; 209(4):165-71. PubMed ID: 9340426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.